VANCOUVER, BC and MESA, AZ, June 19, 2013 /CNW/ - Avidus Management
Group Inc. ("Avidus" or the "Company") (TSX-V: AVD, OTC: ASNHF) and its
wholly owned subsidiary, Asantae, today announced that it held
strategic meetings for its key distributors at an exclusive resort in
Scottsdale, Arizona during the weekend of June 9th.
At the meeting, a standardized plan for leadership, events, recognition,
awards, and training systems was introduced. Avidus' new President,
Doug Ridley said, "The key to growth and sustainability in
network-marketing revolves around a standardized system and model for
sales, recruiting, and distributor development. I was excited to
introduce these programs to those in attendance."
Mr. Ridley also revealed F.A.S.T., an Avidus developed training system
for network marketers. He commented, "F.A.S.T. is the backbone upon
which we will create and introduce our distributor tools. It is a
disciplined and duplicable system for building and sustaining long-term
growth in network-marketing."
In addition, insight was given to the near-term product roadmap. Dan
Lundell, Avidus CEO, explained, "Our product development program
strictly adheres to our core mission to address chronic low-grade
inflammation, which is among the leading causes of modern disease. I
look forward to revealing more information about our newest product
Additional information about the new product launch will be announced in
Neither the TSX Venture Exchange nor its Regulation Services Provider
(as that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
Avidus Management Group Inc. (www.asantae.com) (TSX-V: AVD, OTC: ASNHF) through its wholly owned subsidiary, Asantae,
is a producer and marketer of innovative nutritional products through
direct and network marketing channels. The ingredients in Avidus'
products have been shown to reduce chronic low-grade inflammation and
oxidative stresses which, according to scientific and medical research,
are the underlying conditions for most modern epidemic diseases
(diabetes, heart disease, obesity, stroke, etc.).
This news release may contain forward-looking statements relating to the
Company's operations or to the environment in which it operates. Such
statements are based on operations, estimates, forecasts and
projections. They are not guarantees of future performance and involve
risks and uncertainties that are difficult to predict and may be beyond
the Company's control. A number of important factors could cause actual
outcomes and results to differ materially from those expressed in
forward-looking statements, including those set forth in the Company's
regulatory filings. In addition, such statements relate to the date on
which they are made and the Company disclaims any intention or
obligation to update or revise any forward-looking statements, whether
as a result of new information, future events or otherwise, save and
except as may be required by applicable securities laws.
SOURCE: Avidus Management Group Inc.
For further information:
For further information respecting the Company please contact:
Avidus Management Group, Inc.
Dan Lundell, CEO/COO
10153 E Hampton Ave, Ste 101, Mesa, AZ, 85209 USA
P: 480-278-8712 / F: 480-383-6147
Sequoia Partners Inc.